NOTE 18 – OPTIONS AND WARRANTS
During the six months ended June 30, 2025, 30,000,000 warrants for common stock were issued, having a seven-year period during which the warrants can be exercised at $0.0003 per share were issued to investors. The warrants have been valued at $14,972 and were charged to loss on issuance.
For the six months ended June 30, 2025 and year ended December 31, 2024, a summary of the Company’s warrant activity is as follows:
| Schedule of warrant activity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
Number of
Warrants |
|
|
Weighted-
Average
Exercise Price |
|
|
Weighted-
Average
Remaining
Contractual
Term (Years) |
|
|
Weighted-
Average
Grant-Date
Fair Value |
|
|
Aggregate
Intrinsic
Value |
|
| Outstanding and exercisable at December 31, 2024 |
|
|
333,696,913 |
|
|
$ |
0.0004 |
|
|
|
5.98 |
|
|
$ |
0.0078 |
|
|
$ |
491,376 |
|
| Issued and exercisable during the six months ended June 30, 2025 |
|
|
30,000,000 |
|
|
|
0.0003 |
|
|
|
6.75 |
|
|
|
0.0005 |
|
|
|
16,500 |
|
| Outstanding and exercisable at June 30, 2025 |
|
|
363,696,913 |
|
|
$ |
0.00078 |
|
|
|
5.59 |
|
|
$ |
0.00174 |
|
|
$ |
24,015 |
|
Stock Options Issued
For the six months ended June 30, 2025 and the year ended December 31, 2024, a summary of the Company’s stock options activity is as follows:
| Schedule of stock option activity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
Number of
Options |
|
|
Weighted-
Average
Exercise Price |
|
|
Weighted-
Average
Remaining
Contractual
Term (Years) |
|
|
Weighted-
Average
Grant-Date
Fair Value |
|
|
Aggregate
Intrinsic
Value |
|
| Outstanding and exercisable at December 31, 2024 |
|
|
611,214 |
|
|
$ |
1.00 |
|
|
|
8.75 |
|
|
$ |
0.004 |
|
|
$ |
2,750 |
|
| Issued during the six months ended June 30, 2025 |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
| Outstanding and exercisable at June 30, 2025 |
|
|
611,214 |
|
|
$ |
1.00 |
|
|
|
8.25 |
|
|
$ |
0.004 |
|
|
$ |
(610,694 |
) |
|